Publications by authors named "Christina Dam Bjerregaard Sillassen"
Article Synopsis
- Semaglutide is a medicine that helps people with type 2 diabetes and weight issues by lowering blood sugar and promoting weight loss, but its side effects for different patients haven’t been fully studied yet.!
- A systematic review is planned to look into the risks and side effects of semaglutide by analyzing various clinical trials, with a focus on comparing it to a placebo (a fake treatment) and looking at serious health outcomes.!
- The results of this review will be shared in scientific journals, but right now, they are still in the planning stages and haven’t gathered any data yet.!
